(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

KYMERA

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: Estados Unidos

Snapshot rápido

KYMERA

ST13

US500000090981116

Classe

42

Pedido

90981116

Registro

7559572

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

64

Atualização mais recente

15/03/2026

Tipo de marca

Mista

Classes Nice

42

Data de depósito

16/11/2020

Data de registro

05/11/2024

Data de expiração

-

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

05/11/2024

Última transação

15/03/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Primeiro uso

31/10/2017

Primeiro uso no comércio

31/10/2017

Código do desenho

3

Tipo de titular

03

Localização do titular

Watertown, MA, US

Examinador

DUFFIN, GRACE M

Unidade examinadora

N20

Localização atual

PUBLICATION AND ISSUE SECTION

Descrição da marca

The mark consists of several geometric designs that form the basic elements of an animal face, with the wording "KYMERA" in capital stylized letters appearing to the right of the design and the "K" forming the base of the face.

Titulares e representantes

Titulares

Kymera Therapeutics, Inc.

Representantes

Lisa M. Tittemore Merchant & Gould P.C.

Classificação técnica

Classes Nice

Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 42

Research and development of therapeutic drugs for the treatment of oncologyautoimmuneimmune-oncology and other related diseases; Research and development of pharmaceuticalsresearch and development of technology in the field of pharmaceuticals; Development of pharmaceutical preparations and medicines; Drug development and discovery; Medical research for development of therapeutic modalities for treatment of diseases; Clinical studies; Preclinical and clinical development of therapeutic products

Publicações

Histórico de despachos e eventos da marca no USPTO.

64 publicações encontradas

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

13/03/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

13/03/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

13/03/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/06/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/06/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/06/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/11/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

05/11/2024

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

12/09/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

12/09/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

12/09/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

17/07/2024

DPCC

DIVISIONAL PROCESSING COMPLETE

17/07/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/07/2024

EX5G

SOU EXTENSION 5 GRANTED

10/07/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

26/06/2024

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

26/06/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

26/06/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

26/06/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

26/06/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

26/06/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

26/06/2024

INCD

ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST

12/06/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

24/05/2024

IUAF

USE AMENDMENT FILED

26/04/2024

DRRR

DIVISIONAL REQUEST RECEIVED

26/04/2024

EXT5

SOU EXTENSION 5 FILED

26/04/2024

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

26/04/2024

EISU

TEAS STATEMENT OF USE RECEIVED

26/04/2024

EEXT

SOU TEAS EXTENSION RECEIVED

26/04/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

19/10/2023

EX4G

SOU EXTENSION 4 GRANTED

17/10/2023

EXT4

SOU EXTENSION 4 FILED

17/10/2023

EEXT

SOU TEAS EXTENSION RECEIVED

17/10/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

20/04/2023

EX3G

SOU EXTENSION 3 GRANTED

18/04/2023

EXT3

SOU EXTENSION 3 FILED

18/04/2023

EEXT

SOU TEAS EXTENSION RECEIVED

18/04/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

21/10/2022

EX2G

SOU EXTENSION 2 GRANTED

19/10/2022

EXT2

SOU EXTENSION 2 FILED

19/10/2022

EEXT

SOU TEAS EXTENSION RECEIVED

19/10/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

27/04/2022

EX1G

SOU EXTENSION 1 GRANTED

25/04/2022

EXT1

SOU EXTENSION 1 FILED

25/04/2022

EEXT

SOU TEAS EXTENSION RECEIVED

25/04/2022

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

26/10/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

31/08/2021

PUBO

PUBLISHED FOR OPPOSITION

31/08/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/08/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

27/07/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/07/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/07/2021

ALIE

ASSIGNED TO LIE

01/07/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/05/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

23/04/2021

GNRT

NON-FINAL ACTION E-MAILED

23/04/2021

CNRT

NON-FINAL ACTION WRITTEN

23/04/2021

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

23/04/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

23/04/2021

DOCK

ASSIGNED TO EXAMINER

22/04/2021

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

15/01/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

14/01/2021

NWAP

NEW APPLICATION ENTERED

19/11/2020

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace KYMERA ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.